Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
37 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
000682-AR
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus
Recruitment has not started
18-80 Years
NIAMS
Atherosclerosis
20-NR-0124
Development of Immersive VR Environments to Induce and Evaluate Cognitive Fatigability: User Experience and Healthy Control Studies
No longer recruiting/follow-up only
18-75 Years
NINR
Susceptibility
20-HG-0090
Genetics of COVID-19 Susceptibility and Manifestations
Clinical hold/Recruitment or enrollment suspended
0-125 Years
NHGRI
Susceptibility
20-H-0044
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Atherosclerosis
19-H-0139
Investigation of the Natural Progression of Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance.
Participants currently recruited/enrolled
18-125 Years
NHLBI
Atherosclerosis
16-H-0129
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Completed Study; data analyses ongoing
18-39 Years
NHLBI
Atherosclerosis
15-H-0024
Genes Involved in Lipid Disorders
Completed Study; data analyses ongoing
2-99 Years
NHLBI
Atherosclerosis
15-AR-0060
The Role of PPAR-gamma Agonists in immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Completed Study; data analyses ongoing
18-99 Years
NIAMS
Atherosclerosis
13-H-0065
Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic Disease (PACI) Initiative
No longer recruiting/follow-up only
18-125 Years
NHLBI
Atherosclerosis
12-N-0122
Integrating Genetic and Environmental Risk Scores into an Algorithm to Predict Multiple Sclerosis Susceptibility
Completed Study; data analyses ongoing
18-125 Years
NINDS
Susceptibility
12-H-0092
An Intravenous, Open-Label, Single-Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of rhLCAT in Patients with Stable Coronary Artery Disease
Completed Study; data analyses ongoing
30-75 Years
NHLBI
Atherosclerosis
11-E-0006
The Role of TGF-Beta in Asthmatic Epithelial Cell Susceptibility to RSV Infection
Completed Study; data analyses ongoing
18-60 Years
NIEHS
Susceptibility
11-DK-0168
Magnetic Resonance of Body, Arterial Wall, and Angiography Imaging for Non- Invasive Assessment of Arterial Distensibility, Endothelial Dysfunction and Atherosclerotic Disease Using 1.5T and High Field (3T) MRI: A Technical Development Study of Cardiac a
Participants currently recruited/enrolled
18-125 Years
NIDDK
Atherosclerosis
10-I-0216
Studies of Disorders with Increased Susceptibility to Fungal Infections
Participants currently recruited/enrolled
0-125 Years
NIAID
Susceptibility
10-H-0126
Cardiovascular Disease Discovery Protocol
Participants currently recruited/enrolled
1-100 Years
NHLBI
Atherosclerosis
10-E-0129
Study of the Effect of Innate Immunity on the Inflammatory Response to Endotoxin
Participants currently recruited/enrolled
18-125 Years
NIEHS
Atherosclerosis
10-DK-N091
Molecular and Clinical Profile of Diabetes Mellitus and its Complications
Participants currently recruited/enrolled
18-125 Years
NIDDK
Susceptibility
10-DK-0102
Clinical and Genetic Studies in Familial Non-Medullary Thyroid Cancer
Participants currently recruited/enrolled
7-125 Years
NIDDK
Susceptibility
09-I-0133
Establishing Fibroblast-derived Cell Lines from Skin/Tissue Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders
Enrolling by Invitation
2-85 Years
NIAID
Susceptibility
09-H-0172
Natural History of Bronchiectasis
Participants currently recruited/enrolled
5-125 Years
NHLBI
Susceptibility
07-I-0033
Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility
Participants currently recruited/enrolled
0-125 Years
NIAID
Susceptibility
07-HG-0002
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study
No longer recruiting/follow-up only
6-95 Years
NHGRI
Atherosclerosis
07-H-0142
Research Respiratory Tract Procedures
Participants currently recruited/enrolled
10-125 Years
NHLBI
Susceptibility
06-I-0015
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Participants currently recruited/enrolled
0-125 Years
NIAID
Susceptibility
03-H-0280
Disease Pathogenesis and Natural History of Lipid Disorders
Participants currently recruited/enrolled
2-100 Years
NHLBI
Atherosclerosis
02-C-0212
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed Study; data analyses ongoing
18-100 Years
NCI
Susceptibility
02-C-0052
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study
Participants currently recruited/enrolled
0-125 Years
NCI
Susceptibility
01-DK-N117
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NIDDK
Susceptibility
00-I-0159
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Participants currently recruited/enrolled
0-125 Years
NIAID
Atherosclerosis
99-C-0099
Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Participants currently recruited/enrolled
0-125 Years
NCI
Susceptibility
95-M-0150
A Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings
Participants currently recruited/enrolled
18-55 Years
NIMH
Susceptibility
89-I-0158
Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes
Participants currently recruited/enrolled
2-125 Years
NIAID
Susceptibility
88-I-0083
Host Response to Infection and Treatment in the Filarial Diseases of Humans
Participants currently recruited/enrolled
3-100 Years
NIAID
Susceptibility
85-H-0105
Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia
Completed Study; data analyses ongoing
2-70 Years
NHLBI
Atherosclerosis
79-H-0100
Teaching Protocol for the Evaluation of Plasma Lipoproteins
No longer recruiting/follow-up only
2-99 Years
NHLBI
Atherosclerosis
78-C-0039
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
No longer recruiting/follow-up only
0-125 Years
NCI
Susceptibility
76-H-0051
Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients
Completed Study; data analyses ongoing
18-80 Years
NHLBI
Atherosclerosis